| Product NDC: | 45802-660 |
| Proprietary Name: | Clindamycin Phosphate |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 10 mg/g & nbsp; clindamycin phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | AEROSOL, FOAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-660 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090785 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100331 |
| Package NDC: | 45802-660-33 |
| Package Description: | 1 CAN in 1 CARTON (45802-660-33) > 100 g in 1 CAN |
| NDC Code | 45802-660-33 |
| Proprietary Name | Clindamycin Phosphate |
| Package Description | 1 CAN in 1 CARTON (45802-660-33) > 100 g in 1 CAN |
| Product NDC | 45802-660 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | AEROSOL, FOAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100331 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |